These chemicals are involved in transmitting nerve signals in your central nervous system ( brain and spinal cord )
Do not crush or chew the capsule or mix the contents with food or liquid
Duloxetine is available under the following different brand and other names: Cymbalta
Takeaway Drug Images Cymbalta (duloxetine) is a brand-name drug that’s prescribed for certain conditions, including depression
Cymbalta dosing for adults 65 years
Duloxetine, sold under the brand name Cymbalta among others, [1] is a medication used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic
Cymbalta is available as a generic under the name duloxetine
Find out how duloxetine treats depression, anxiety, nerve pain and urinary incontinence, and how to take it
aztreonam
Cymbalta (Duloxetine) Cymbalta (duloxetine) is commonly used to treat depression and generalized anxiety
Common Interactions
The most common version of Cymbalta is covered by 62% of insurance plans
To help make it easier to come off Cymbalta, your doctor will likely recommend a taper lasting at least two weeks
1 Inhibitors of CYP1A2 7
, NSAIDs, Cymbalta is a brand name for the generic drug duloxetine, a type of medication called a serotonin and norepinephrine reuptake inhibitor
increased anxiety
1 Major Depressive Disorder Cymbalta is indicated for the treatment of major depressive disorder (MDD)
Comparing the prices of brand-name Cymbalta and its generic version, duloxetine, you may notice a significant difference
Cymbalta is used to treat or manage Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain
Swallow Cymbalta capsules whole; do not crush, chew, or open up the capsules and
Official answer
However, with proper use under a doctor’s or medical professional’s supervision, side effects and adverse effects often resolve, and Cymbalta can improve overall mental health and well-being over time
, discontinuation occurring in at least 1% of the CYMBALTA-treated patients and at a rate of at least twice that of placebo-treated patients)
Patients should be cautioned about the risk of bleeding associated with the concomitant use of duloxetine and NSAIDs, aspirin, or other drugs that affect coagulation (5